GET DAILY SIGNALSJIRE vs VEA: Contrasting Active and Passive Strategies in Developed Ex-U.S. Equities
Key Takeaways
- Strategy type: JIRE is an actively managed, research-enhanced fund seeking to beat the MSCI EAFE Index; VEA is a passive, market-cap-weighted index fund.
- Breadth: JIRE holds roughly 220 stocks concentrated in developed markets excluding North America, while VEA holds close to 4,000 stocks across developed markets ex-U.S., including Canada and South Korea.
- Cost: VEA carries a 0.03% expense ratio versus 0.24% for JIRE, a meaningful long-term cost gap.
- Sector exposure: Both funds lean on financials and industrials, but VEA has higher technology weight while JIRE runs larger financials and healthcare tilts.
- Tickeron AI Verdict: On balance, Tickeron's AI would favor VEA for its lower cost, broader diversification, and consistent structural efficiency.
Why International Equity Exposure Matters
International equity exposure is one of the most important, and most debated, decisions in portfolio construction. JIRE and VEA both give investors access to developed-market stocks outside the United States, yet they pursue that goal through fundamentally different structures. JIRE is an actively managed, research-enhanced fund built around the MSCI EAFE universe, while VEA is a broad passive index tracker covering nearly 4,000 companies. For investors weighing active management against low-cost indexing, this ETF comparison highlights how structure, cost, and diversification shape fund performance and relative positioning. I also checked this using Tickeron’s AI Screener to see how the two line up on key metrics.
Understanding JIRE: JPMorgan's Research-Enhanced Approach
JIRE is an actively managed ETF from J.P. Morgan that seeks long-term capital appreciation by outperforming the MSCI EAFE Index (Europe, Australasia and Far East) over time while maintaining similar risk characteristics. The fund invests at least 80% of assets in equity securities and focuses on developed markets excluding North America, meaning it does not hold Canadian stocks. The portfolio holds roughly 220 positions, a concentrated approach relative to broad index funds, with a net expense ratio of 0.24% (0.29% gross).
Top holdings include ASML, AstraZeneca (AZN), Siemens, Allianz, Roche, Shell (SHEL), HSBC (HSBC), Banco Santander (SAN), Nestlé, and Novartis (NVS). Sector allocations are led by financials (roughly 25%), industrials (about 17%), technology (around 11–12%), and healthcare (about 11%). Geographically, the fund skews toward the Eurozone, Japan, and the United Kingdom. As an actively managed vehicle, JIRE relies on manager research and fundamental analysis rather than mechanical index replication. From what I see, the active tilt shows up most clearly in the heavier financials and healthcare weights.
VEA: Vanguard's Broad Passive Exposure
VEA is a passively managed ETF that tracks the FTSE Developed All Cap ex U.S. Index, a market-capitalization-weighted benchmark spanning large-, mid-, and small-cap companies across Canada, Europe, and the Pacific region. The fund holds approximately 3,900 to 4,000 stocks, providing far broader diversification than a concentrated active fund. Its expense ratio is just 0.03%, among the lowest in the international equity category, and it benefits from substantial assets under management (AUM) and deep liquidity.
Top holdings include Samsung Electronics, SK hynix, ASML, HSBC (HSBC), Roche, Royal Bank of Canada (RY), Novartis (NVS), AstraZeneca (AZN), Nestlé, and Shell (SHEL). Sector exposure is led by financials (about 22–24%), industrials (around 18%), and technology (roughly 16–17%), with smaller positions in healthcare, basic materials, and consumer cyclical. Unlike JIRE, VEA includes Canadian companies and South Korean technology leaders such as Samsung Electronics and SK hynix. One thing that stands out here is how the inclusion of those additional markets changes the risk profile.
Market Context and Key Drivers
Both funds operate in the developed international equity space, where several macro forces are converging. Interest-rate expectations across Europe and Japan, currency movements, and the earnings cycles of large financial and industrial companies are central drivers. A stronger or weaker U.S. dollar directly influences returns for U.S.-based holders of these funds. Meanwhile, global semiconductor demand has made technology names such as ASML, Samsung, and SK hynix increasingly influential. European banks and insurers have also benefited from higher rates in recent cycles. Risks include geopolitical tension, uneven economic growth across the Eurozone and Asia, and concentration in a handful of mega-cap names that increasingly dominate index weightings. I’m watching this closely because currency and rate shifts can quickly alter relative performance.
How the Two Funds Compare in Performance and Positioning
In recent weeks and over recent market cycles, the two funds have tracked similar broad international themes but with different emphasis. VEA's larger technology allocation has allowed it to capture more of the semiconductor-driven rally, while JIRE's heavier financials and industrials tilts have positioned it toward value and cyclical segments. JIRE's active managers can adjust weightings as conditions shift, which may help or hurt relative results depending on the cycle. VEA, by contrast, offers lower cost and broad diversification that tends to reduce single-stock risk. Both funds carry a beta (a measure of volatility versus the broad market) below 1.0, reflecting the generally lower volatility of international developed equities, though their currency and regional exposures remain meaningful risk factors.
Exploring Tickeron’s AI Tools in ETF Research
In my own analysis, I turned to Tickeron’s AI tools to cross-check sector weights and diversification metrics between the two ETFs. The platform’s pattern recognition and signal filters helped surface how VEA’s broader holdings might behave across different market regimes, while also highlighting JIRE’s active tilts. It’s become a regular part of my workflow when comparing funds like these, especially for spotting structural differences that aren’t always obvious from standard factsheets.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
VEA's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for VEA turned positive on November 09, 2026. Looking at past instances where VEA's MACD turned positive, the stock continued to rise in 41 of 44 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 58 cases where VEA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on VEA as a result. In 62 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a +0.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where VEA advanced for three days, in 266 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
VEA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VEA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for VEA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
Advertisement